Probe & go Labor Labordiagnostica GmbH
Medical Technology · Lippe
Probe & go Labor Labordiagnostica GmbH is a medical technology company based in Lippe, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Probe & go Labor Labordiagnostica GmbH Address & Contact
Probe & go Labor Labordiagnostica GmbH at a Glance
Probe & go Labor Labordiagnostica GmbH in the Lippe district of North Rhine-Westphalia is a company specialized in laboratory diagnostics and point-of-care diagnostics. It focuses on the development and distribution of diagnostic testing systems, rapid tests, and laboratory analysis devices for medical practices, hospitals, and diagnostic facilities in NRW. With a high standard for precision and speed, Probe & go offers innovative solutions that are used for efficient patient care in both outpatient and inpatient settings. The company’s expertise extends over several decades and is designed to support medical professionals in improving diagnoses and treatment decisions.
Services and Products
The product portfolio of Probe & go includes a wide range of diagnostic rapid tests aimed at infectious diseases such as COVID-19, influenza, and streptococci. Additionally, tests for inflammatory markers and various clinical parameters are offered. The point-of-care analysis systems enable immediate diagnostics in medical practices, facilitating prompt medical decision-making. Robust technical support and comprehensive training programs for medical staff ensure that all diagnostic systems can be optimally utilized.
- Rapid tests: Diagnostic tests for respiratory diseases, gastrointestinal infections, and allergies.
- Laboratory analysis devices: Devices for the analysis of blood lipids, blood sugar, and other important health parameters.
- Point-of-Care Diagnostics: Mobile diagnostic equipment for use directly at the patient's bedside.
- Technical Support: Comprehensive assistance for the implementation and maintenance of the diagnostic systems.
All products are certified as in vitro diagnostics under the EU Regulation on In Vitro Diagnostic Devices (EU-IVDR). This ensures that they meet the highest quality and safety standards. Probe & go places special emphasis on rapid availability and reliable result quality of its diagnostic products, which are crucial for patient care.
Location Lippe / North Rhine-Westphalia
The Lippe district, nestled in the Ostwestfalen-Lippe region of North Rhine-Westphalia, offers a dynamic healthcare landscape. This region is known for its numerous medical practices, hospitals, and medical facilities that rely on modern and reliable diagnostic solutions. With over 18 million residents, North Rhine-Westphalia is one of the most populous federal states in Germany, and therefore represents a significant market for medical technology products.
The proximity to important traffic axes and the close cooperation with specialized laboratories and diagnostic centers strengthen Probe & go’s position in the regional medical technology industry. The company regularly collaborates with universities and research institutions to promote innovative technologies and product developments that can simplify and improve diagnostics.
Regulatory Classification and Particularities
Probe & go Labor Labordiagnostica GmbH operates under strict regulatory guidelines applicable to manufacturers of in vitro diagnostics. The strict adherence to EU-IVDR certification is not only a quality feature but also an expression of the company’s responsibility towards end consumers and medical professionals. In addition, like all medical technology companies in Germany, the company is subject to continuous monitoring by the competent authorities to ensure the safety and effectiveness of its products.
A particularity of the company is its agile response to market developments, enabling it to offer rapidly adaptable solutions. This is exemplified by the swift development and deployment of COVID-19 rapid tests during the pandemic, when efficient diagnostic solutions were needed in record time. This flexibility and innovative power make Probe & go a significant player in medical technology and laboratory diagnostics.
Other medical technology companies: Medical Technology Overview | Laboratories | Pharmaceutical Companies
```Frequently asked questions about Probe & go Labor Labordiagnostica GmbH
What does Probe & go Labor Labordiagnostica GmbH do?
Probe & go Labor Labordiagnostica GmbH is a company in the medical technology sector based in Lippe. The company develops, produces or distributes medical devices, instruments or systems for use in healthcare facilities.
Where is Probe & go Labor Labordiagnostica GmbH located?
Probe & go Labor Labordiagnostica GmbH is headquartered in Lippe. More information can be found on the company's website.
In which area of medical technology is Probe & go Labor Labordiagnostica GmbH active?
Probe & go Labor Labordiagnostica GmbH is active in the medical technology sector and offers solutions for medical facilities, clinics and practices. You can find the exact areas of focus on the company's website.
More Medical Technology in Lippe
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.